Study at new Ivy Brain Tumor Center is a novel first-in-human phase 0 clinical trial study led by Dr. Nader Sanai at Barrow Neurological Institute, in collaboration with Karmanos Cancer Institute and Translational Genomics Institute.
Author Archive: AZBio
CBR Announces Positive Results for First Study Administering Cord Blood to Children with Hearing Loss
CBR® (Cord Blood Registry®), the world’s largest newborn stem cell company, has announced the publication of the results of the first clinical trial evaluating the use of autologous umbilical cord blood in children with acquired sensorineural hearing loss (SNHL).Continue reading
Opportunity Alert – Call for Sessions is Open for BIO 2019
Scientific progress begins with one idea, one theory, one trial, one success. The small initiatives of today—the incremental investments of time, energy, and dedication that each of us makes—can have a global impact on tomorrow. Our theme highlights the critical daily contributions that combine to bring new breakthroughs to the world. And yes, it can start with one front-office executive or hiring manager resolving to discover new talent or make an inspired promotion that brings vital new voices to the table.Continue reading
Clara Curiel-Lewandrowski, MD, of the University of Arizona Cancer Center Named 2018 Arizona Bioscience Researcher of the Year
CHANDLER, Ariz — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced that Clara Curiel-Lewandrowski, MD, of the University of Arizona Cancer Center is the 2018 Arizona Bioscience Researcher of the Year. Dr. Curiel will be honored by Arizona’s bioscience and business communities for her leadership and her work on both the treatment and prevention of skin cancers at the AZBio Awards on October 3, 2018, at the Phoenix Convention Center.Continue reading
The Arizona Bioscience Company of the Year is on a Mission to Cure the Uncurable
Calimmune, Inc., acquired by global biotechnology leader CSL Limited in 2017 and now fully integrated within CSL, to be honored as the Arizona Bioscience Company of the Year at the 2018 AZBio Awards.Continue reading
Guest Post: Are You Ready for Regulatory Football?
Staying abreast of regulatory changes can be a game changer for your businessContinue reading
NIH-supported Kids First Data Resource Portal Launches
TGen participates in today’s launch of NIH-supported Kids First Data Resource Portal.
TGen and PNOC genomics data from a children’s brain cancer clinical trial to be included in national initiativeContinue reading
Arizona Bioscience Community to Honor Dr. Michael E Berens of TGen for Leadership
CHANDLER, Ariz — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced today that Michael E. Berens, PhD, Professor; Deputy Director for Research Resources; and Director of the Cancer and Cell Biology Division at the Translational Genomics Research Institute (TGen) is the Jon W. McGarity Arizona Bioscience Leader of the Year. Dr. Berens will be honored by Arizona’s bioscience and business communities for his leadership and his contributions to building the coalitions that have shaped the state’s life science industry at the 2018 AZBio Awards on October 3, 2018 at the Phoenix Convention Center.Continue reading